Caplight Directory>Companies>Selecxine-preview>Selecxine


Selecxine

Selecxine

Private
PohangHealthcare & Life Scienceshttp://selecxine.com

Last Round

Series B

Mar 29, 2022

Total Funding Raised

$38.15M

Company Overview

Selecxine is a South Korea-based biopharmaceutical company founded in 2018 that develops anti-cancer immunotherapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

cancer immunotherapyimmuno-oncologyIL-2 therapyengineered cytokinesolid tumor therapyantibody conjugateclinical stage biotechantibody discovery platformantibody engineeringcytokine regulationcompanion diagnosticsCDMO partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Selecxine Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Selecxine Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMar 29, 2022
Series AMay 7, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

GilTae Wie

COO CFO

Executive Team

Selecxine Investors

Notable investors and investment history

InvestorRounds
Hanwha Investment & SecuritiesSeries A, Series B
UTC InvestmentSeries B
Medici InvestmentSeries B
K-Run VenturesSeries A
Stonebridge VenturesSeries A, Series B
BM VenturesSeries A
Hyundai Technology InvestmentSeries B
View all Investors

Selecxine Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Selecxine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Selecxine's valuation, stock price, and market status.

Firmographic Details

HeadquartersPohang
Employee Range9
Year Founded2018
Last FundingMar 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.